# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Meningioma

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 44 results.
Vistusertib (AZD2014) For Recurrent Grade II-III Meningiomas
Status: Recruiting
Last Changed: Nov 13, 2019
First Received: Mar 07, 2017
Disease(s): Meningioma
Intervention(s): AZD2014
Locations: Northwestern University, Chicago, Illinois, United States
Massachusetts general Hospital, Boston, Massachusetts, United States
Dana Farber Cancer Institute, Boston, Massachusetts, United States
An Open-Label Phase II Study of Nivolumab in Adult Participants With Recurrent High-Grade Meningioma
Status: Recruiting
Last Changed: Mar 25, 2020
First Received: Jan 07, 2016
Disease(s): Meningiomas
Intervention(s): Nivolumab - 240 mg, Ipilimumab - 3 mg/kg, Nivolumab - 480 mg, Nivolumab - 1 mg/kg, External Beam RT
Locations: Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Phase II Trial of Pembrolizumab in Recurrent or Residual High Grade Meningioma
Status: Recruiting
Last Changed: Aug 14, 2019
First Received: Sep 12, 2017
Disease(s): High Grade Meningioma
Intervention(s): Pembrolizumab
Locations: Dana Farber Cancer Institute, Boston, Massachusetts, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
MEningioma Detection Using Non Contrast MRI TecHniquEs
Status: Not yet recruiting
Last Changed: Feb 06, 2020
First Received: Oct 02, 2019
Disease(s): Meningioma
Intervention(s): FABIR sequence
Locations: Fondation ophtalmique Adolphe de Rothschild, Paris, France
Carbon Ion Radiotherapy for Atypical Meningiomas
Status: Recruiting
Last Changed: Jan 09, 2020
First Received: Jul 21, 2010
Disease(s): Meningioma
Intervention(s): Carbon Ion Radiotherapy
Locations: University Hopsital Heidelberg, Heidelberg, Germany
Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma
Status: Not yet recruiting
Last Changed: Mar 12, 2020
First Received: Mar 12, 2020
Disease(s): Meningioma
Intervention(s): Gleolan (Aminolevulinic Acid Hydrochloride)
Locations: Mayo Clinic, Phoenix, Arizona, United States
University Hospital Münster, Münster, Germany
Gallium Ga 68-DOTATATE PET/CT in Predicting Tumor Growth in Patients With Meningiomas
Status: Recruiting
Last Changed: Feb 13, 2020
First Received: May 16, 2019
Disease(s): Meningioma
Intervention(s): Computed Tomography, Gallium Ga 68-DOTATATE, Positron Emission Tomography
Locations: M D Anderson Cancer Center, Houston, Texas, United States
Concordance and Accuracy of MRI in the Detection of Meningiomas: Optimizing Sequences With Low Doses of Gadolinium
Status: Recruiting
Last Changed: Feb 07, 2020
First Received: Oct 02, 2019
Disease(s): Meningioma
Intervention(s): sequences T1 FE
Locations: Fondation ophtalmique Adolphe de Rothschild, Paris, France
Phase II Study of 177Lu-DOTATATE Radionuclide in Adults With Progressive or High-risk Meningioma
Status: Recruiting
Last Changed: Nov 07, 2019
First Received: Jun 03, 2019
Disease(s): Meningioma
Intervention(s): Lutathera
Locations: NYU Langone Health, New York, New York, United States
Combination of Alpelisib and Trametinib in Progressive Refractory Meningiomas
Status: Not yet recruiting
Last Changed: Aug 17, 2018
First Received: Aug 15, 2018
Disease(s): Meningioma
Intervention(s): Trametinib, Alpelisib, Blood sample, MRI
Locations: Assistance Publique Hôpitaux de Marseille, Marseille, France